2023
DOI: 10.3390/jcm12072523
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Five Presbyopia-Correcting Intraocular Lenses: Optical-Bench Assessment with Visual-Quality Simulation

Abstract: Presbyopia correction through implantation of a trifocal intraocular lens (IOL) is a modality offered to both cataract and refractive-lens exchange patients. To maximize postoperative satisfaction, IOL selection needs to be made based on patients’ requirements aligned with the available technology. Five Trifocal IOLs were assessed in this study, and their differentiating features were identified: Triumf POD L GF, AT Lisa Tri, Tecnis Synergy, AcrySof IQ PanOptix, and Acriva Trinova Pro C. The optical quality wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(1 citation statement)
references
References 31 publications
(49 reference statements)
0
1
0
Order By: Relevance
“…While comparable results to the AT LISA tri were observed for −1D and −3D, a half-a-line improvement in VA was noticeable at −2D. Although a close alignment of the simulated and clinical defocus curves has been demonstrated, 14,17,21 the optical bench analysis only approximates the in vivo performance, corresponding to the average eye rather than an individual patient. Therefore, these simulated VA values must be confirmed once clinical trial results become available.…”
Section: Discussionmentioning
confidence: 58%
“…While comparable results to the AT LISA tri were observed for −1D and −3D, a half-a-line improvement in VA was noticeable at −2D. Although a close alignment of the simulated and clinical defocus curves has been demonstrated, 14,17,21 the optical bench analysis only approximates the in vivo performance, corresponding to the average eye rather than an individual patient. Therefore, these simulated VA values must be confirmed once clinical trial results become available.…”
Section: Discussionmentioning
confidence: 58%